Calendrier des promotions DexCom, Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise DexCom, Inc.
DexCom, Inc., компания по производству медицинского оборудования, занимается проектированием, разработкой и коммерциализацией систем непрерывного мониторинга уровня глюкозы (CGM) в США и за рубежом. Компания предоставляет свои системы для использования людьми с диабетом, а также для использования поставщиками медицинских услуг. plus de détails| IPO date | 2005-04-14 |
|---|---|
| ISIN | US2521311074 |
| Industry | Health Care Equipment & Supplies |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | https://www.dexcom.com |
| Цена ао | 72.13 |
| Changement de prix par jour: | +2.23% (81.53) |
|---|---|
| Changement de prix par semaine: | +16.77% (71.38) |
| Changement de prix par mois: | +35.24% (61.63) |
| Changement de prix sur 3 mois: | -6.12% (88.78) |
| Changement de prix sur six mois: | +20.95% (68.91) |
| Changement de prix par an: | -34.59% (127.42) |
| Evolution du prix sur 3 ans: | -74.05% (321.23) |
| Evolution du prix sur 5 ans: | -78.26% (383.46) |
| Evolution des prix sur 10 ans: | +3.02% (80.91) |
| Evolution des prix depuis le début de l'année: | +7.18% (77.77) |
|
|
Sous-estimation
|
Efficacité
|
|||||||||||||||||||||||||||||||||||||
Dividendes
|
Devoir
|
Impulsion de croissance
|
|||||||||||||||||||||||||||||||||||||
| Établissements | Volume | Partager, % |
|---|---|---|
| Vanguard Group Inc | 44467463 | 11.53 |
| Blackrock Inc. | 32726186 | 8.49 |
| Baillie Gifford and Company | 16520313 | 4.29 |
| State Street Corporation | 16198598 | 4.2 |
| Capital Research Global Investors | 15296032 | 3.97 |
| Sands Capital Management, LLC | 15058806 | 3.91 |
| Capital World Investors | 9278685 | 2.41 |
| Geode Capital Management, LLC | 8917255 | 2.31 |
| FMR, LLC | 8112737 | 2.1 |
| Nuveen Asset Management, LLC | 7492292 | 1.94 |
| ETF | Partager, % | Rentabilité pour l'année, % | Dividendes, % |
|---|---|---|---|
| Global X Telemedicine & Digital Health ETF Registered | 1.90937 | 7.26 | 0.28226 |
| iShares Morningstar Mid-Cap Growth ETF | 0.52082 | 458.38 | 0.94237 |
| Harbor Disruptive Innovation ETF | 0.3338 | 29.05 | 0.39896 |
| iShares Morningstar Mid-Cap ETF | 0.25931 | 260.95 | 1.7458 |
| Nationwide Nasdaq-100 Risk-Managed Income ETF | 0.18478 | 21.38 | 0.87606 |
| Fidelity Growth Opportunities ETF | 0.17739 | -1.24 | 0.48881 |
| iShares Morningstar Large-Cap Growth ETF | 0.11488 | 291.4 | 0.5823 |
| iShares Factors US Growth Style ETF | 0.08184 | 7.44 | 0.7035 |
| iShares Morningstar Large-Cap ETF | 0.05543 | 257.57 | 1.41244 |
| Columbia U.S. ESG Equity Income ETF | 0.04668 | -99.18 | 1.44131 |
| 0.37 | 123.3 | 0.89 |
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
|---|---|---|---|
| Mr. Kevin Ronald Sayer | Executive Chairman, CEO & President | 2.22M | 1958 (67 années) |
| Mr. Jereme M. Sylvain | Executive VP, CFO & Chief Accounting Officer | 841.14k | 1980 (45 années) |
| Mr. Jacob Steven Leach | Executive VP & COO | 994.13k | 1978 (47 années) |
| Mr. Sean Christensen | Director of Corporate Affairs & Head of Investor Relations | N/A | |
| Mr. Matthew Dolan | Executive Vice President of Strategy, Corporate Development & Dexcom Labs | N/A | 1981 (44 année) |
| Mr. Girish Naganathan | Executive VP & CTO | 423.92k | 1977 (48 années) |
| Mr. Michael Jon Brown | Executive VP & Chief Legal Officer | 954.46k | 1970 (55 années) |
| Ms. Leverne Marsh | Executive Vice President of Marketing | N/A | |
| Ms. Teri Lawver | Executive VP & Chief Commercial Officer | 1967 (58 années) | |
| Stacey Stewart | Senior VP & Chief Information Officer |
Adresse: United States, San Diego. CA, 6340 Sequence Drive - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.dexcom.com
Site web: https://www.dexcom.com
